6430 related articles for article (PubMed ID: 22558891)
21. Desmoplastic malignant melanoma.
Frolow GR; Shapiro L; Brownstein MH
Arch Dermatol; 1975 Jun; 111(6):753-4. PubMed ID: 1137419
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features.
Gamblin TC; Edington H; Kirkwood JM; Rao UN
Ann Surg Oncol; 2006 Dec; 13(12):1664-70. PubMed ID: 17024556
[TBL] [Abstract][Full Text] [Related]
23. Double cancer of plantar malignant melanoma and vulvar extramammary Paget's disease.
Tsuji M; Nakai N; Ueda E; Takenaka H; Katoh N; Kishimoto S
J Dermatol; 2010 May; 37(5):484-7. PubMed ID: 20536656
[TBL] [Abstract][Full Text] [Related]
24. Vulvar melanoma: a report of 20 cases and review of the literature.
Wechter ME; Gruber SB; Haefner HK; Lowe L; Schwartz JL; Reynolds KR; Johnston CM; Johnson TM
J Am Acad Dermatol; 2004 Apr; 50(4):554-62. PubMed ID: 15034504
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.
Pawlik TM; Ross MI; Prieto VG; Ballo MT; Johnson MM; Mansfield PF; Lee JE; Cormier JN; Gershenwald JE
Cancer; 2006 Feb; 106(4):900-6. PubMed ID: 16411225
[TBL] [Abstract][Full Text] [Related]
26. Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy.
Pearl RA; Pacifico MD; Richman PI; Wilson GD; Grover R
J Plast Reconstr Aesthet Surg; 2008; 61(3):265-71. PubMed ID: 17569608
[TBL] [Abstract][Full Text] [Related]
27. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?
Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D
J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961
[TBL] [Abstract][Full Text] [Related]
28. [Distinguishing nodal naevus from melanoma metastases in the sentinel node in patients with melanoma].
Witte ME; Gerrits EG; Klaase JM; Mastboom WJ; Sterk LM
Ned Tijdschr Geneeskd; 2006 May; 150(19):1072-6. PubMed ID: 16733984
[TBL] [Abstract][Full Text] [Related]
29. Desmoplastic melanoma of the vulva.
Mulvany NJ; Sykes P
Pathology; 1997 May; 29(2):241-5. PubMed ID: 9213352
[TBL] [Abstract][Full Text] [Related]
30. The correlation of regression in primary melanoma with sentinel lymph node status.
Kaur C; Thomas RJ; Desai N; Green MA; Lovell D; Powell BW; Cook MG
J Clin Pathol; 2008 Mar; 61(3):297-300. PubMed ID: 17675538
[TBL] [Abstract][Full Text] [Related]
31. Rhabdomyosarcomatous (myoblastic?) phenotype of metastatic malignant melanoma. A case report.
Pasz-Walczak G; Jesionek-Kupnicka D; Kubiak R; Biernat W; Sygut J; Kordek R
Pol J Pathol; 2002; 53(2):97-100. PubMed ID: 12140874
[TBL] [Abstract][Full Text] [Related]
32. S100, HMB-45, and Melan-A negative primary melanoma.
Shinohara MM; Deubner H; Argenyi ZB
Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
[TBL] [Abstract][Full Text] [Related]
33. Neurotropic desmoplastic melanoma: a rare vulvar malignancy.
Byrne PR; Maiman M; Mikhail A; Harris M; Rosen Y
Gynecol Oncol; 1995 Feb; 56(2):289-93. PubMed ID: 7896200
[TBL] [Abstract][Full Text] [Related]
34. MCW melanoma cocktail for the evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma.
Shidham VB; Chang CC; Komorowski R
Expert Rev Mol Diagn; 2005 May; 5(3):281-90. PubMed ID: 15934808
[TBL] [Abstract][Full Text] [Related]
35. Melanoma in children and the use of sentinel lymph node biopsy.
Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
[TBL] [Abstract][Full Text] [Related]
36. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
[TBL] [Abstract][Full Text] [Related]
37. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors).
Murali R; Sharma RN; Thompson JF; Stretch JR; Lee CS; McCarthy SW; Scolyer RA
Ann Surg Oncol; 2008 Jan; 15(1):302-9. PubMed ID: 18000712
[TBL] [Abstract][Full Text] [Related]
39. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.
Sassen S; Shaw HM; Colman MH; Scolyer RA; Thompson JF
Ann Surg Oncol; 2008 Feb; 15(2):630-7. PubMed ID: 18080717
[TBL] [Abstract][Full Text] [Related]
40. Amelanotic vulvar melanoma: case report and review of the literature.
Baderca F; Cojocaru S; Lazăr E; Lăzureanu C; Lighezan R; Alexa A; Raica M; Nicola T
Rom J Morphol Embryol; 2008; 49(2):219-28. PubMed ID: 18516330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
